Aniruddh Sarkar is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University where he leads the Micro/Nano Bioelectronics Lab. He was earlier a Research Fellow at the Ragon Institute of MGH, MIT and Harvard with research affiliations at Harvard Medical School and at MIT. His research has evolved around the theme of exploiting unique physical phenomena that occur at the micrometer to nanometer length scales to develop devices and systems for solving various technological problems with a special focus on applications in biology and medicine. His earlier work, with Prof. Galit Alter (MGH/HMS) and Prof. Jongyoon Han (MIT), involved the development and application of microfabricated and nanofabricated devices to further the prevention, diagnosis and therapy of infectious diseases such as Tuberculosis and HIV/AIDS. He received his Ph.D in Electrical Engineering and Computer Science with a minor in Biology at MIT, developing microfluidic tools for single-cell analysis. He received his bachelors and masters degrees, both in Electrical Engineering at IIT Bombay.

Philip Santangelo is a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. He is a member of the Cancer Immunology Research Program at Winship Cancer Institute. 

Dr. Santangelo obtained his Ph.D. in Engineering from the University of California at Davis. He completed his postdoctoral training at Sandia National Laboratories in Livermore, California and at Georgia Tech in Atlanta, Georgia. He also holds an MS in Engineering from Purdue University. 

The overarching theme of the Santangelo lab is the spatial biology of RNA viruses and RNA regulation. Spatial biology is the study of biology in three dimensions — and the Santangelo lab develops advanced imaging tools to achieve this goal. The lab focuses their tools on the spatial biology of HIV/SIV and human respiratory synctial virus (leading cause of bronchiolitis and pneumonia in babies) and the aberrant regulation of messenger RNA during inflammation, viral infections and cancer pathogenesis. They have developed both single molecule methods and whole body imaging methods in order to work towards our goals.

Since joining the faculty in 2012, James Rains has taught two of Tech’s most critical classes for creating the next generation of biomedical engineers. “Intro to Biomedical Engineering Design” and the “Biomedical Engineering Capstone” courses are bookends on the student experience in the BME program, which has consistently ranked among the best in the nation. Meanwhile, Rains helps give students more real-world healthcare problems from clinicians and medical companies than any other BME department in the world. He constantly strives to find the best and most diverse projects for his students, including in 2018, a new collaboration with the world-renowned Mayo Clinic. His BME student teams consistently win top honors in innovation competitions and mentors and coaches Create-X student startups. For all of his tremendous efforts, he was named the 2019 Undergraduate Educator of the Year by Tech’s Center for Teaching and Learning.

Peng Qiu is an Associate Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. 

Dr. Qiu is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He received his Ph.D. in Electrical and Computer Engineering from University of Maryland in College Park, Maryland. 

His research interests are in the areas of bioinformatics and computational biology with a focus on statistical signal processing, machine learning, control systems and optimization. 

As it relates to cancer, he is interested in single-cell analysis, and multi-omics pan-cancer data integration. He is collaborating with Winship investigator Adam Marcus on the analysis of single-cell RNAseq data of leader/follower cells in experiments that study the behavior of collective invasion in cancer.

Erik C. Dreaden joined the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University in 2017. Dr. Dreaden also holds a joint faculty appointment in the Department of Pediatrics at the Emory University School of Medicine where he collaborates with researchers at Children's Healthcare of Atlanta and the Aflac Center for Cancer and Blood Disorders. Dr. Dreaden's research seeks to apply principles of molecular and nanoscale engineering to improve the therapeutic potential of drug combinations, vaccines, and immunotherapies directed against pediatric and adult cancers. 

Prior to joining Emory and Georgia Tech, Dr. Dreaden was a postdoctoral fellow at the Koch Institute for Integrative Cancer Research at MIT, where his research focused on the development of polymer-based technologies for nucleic acid and rational combination cancer therapies. 

Dr. Dreaden is a member of the Cancer Immunology Research Program at the Winship Cancer Institute of Emory University. He also holds memberships in the Biomedical Engineering Society, American Institute of Chemical Engineers, American Association of Cancer Research, Materials Research Society, American Association for the Advancement of Science, and American Chemical Society.

Dr. Davis holds positions as a Professor in both Cardiology and Biomedical Engineering at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Additionally, he serves as an associate chair for graduate studies at BME department, and a director of the Children's Heart Research and Outcomes (HeRO) Center. He received his Ph.D. in Molecular and Systems Pharmacology at Emory University in 2003 working on molecular regulation of eNOS expression by shear stress. From 2003-2006, he completed his postdoctoral fellowship at Brigham and Women's Hospital working on cardiac tissue engineering with collaborators at the Massachusetts Institute of Technology. He moved back to Emory in 2006 to join the faculty in Division of Cardiology and Biomedical Engineering Department.

Lakshmi Prasad Dasi is an established researcher in the field of prosthetic heart valves, cardiovascular biomechanics, biomaterials, and devices. He is currently a tenure Professor of Biomedical Engineering, at Georgia Institute of Technology while holding the Rozelle Vanda Wesley Endowed Professorship as well as being the Associate Chair for Undergraduate Studies. He has held positions at The Ohio State University, and Colorado State University previously. He is a Fellow of the American College of Cardiology (FACC) as well as Fellow of the American Institute for Medical and Biological Engineering (FAIMBE). 

Dasi earned his Ph.D. from Georgia Institute of Technology in 2004 with a focus in fluid dynamics and turbulence. He trained as a postdoctoral fellow and research engineer under Prof. Ajit Yoganathan’s mentorship at Georgia Tech where he transformed his research focus to heart valves, devices, and cardiovascular biomechanics. In 2009, he established the Cardiovascular Biofluid Mechanics Lab (CBFL) as Assistant Professor at Colorado State University and moved to The Ohio State University in 2015 as his focus became more translational. Since 2020, his research at Georgia Tech focuses on tackling the complexity of: (a) heart valve biomechanics (native and prosthetic); (b) prosthetic heart valve engineering (conventional & trans-catheter); (c) structure-function relationships of the heart in health and disease at the embryonic, pediatric, as well as adult stages; and (d) turbulence and turbulent blood flow.

I am the Patsy and Alan Dorris Chair of Pediatric Technology and Professor of Biomedical Engineering at the Georgia Institute of Technology. I also direct the Center for 3D Medical Fabrication (3DMedFab) and the Tissue Engineering and Mechanics Laboratory at Georgia Tech. We develop a range of 3D printed medical devices. We have over 25 devices implanted in patients for treatment of trachecobronchomalacia.

Our work centers on understanding how the brain represents information and intention, and using this knowledge to develop high-performance, robust, and practical assistive devices for people with disabilities and neurological disorders. We take a dynamical systems approach to characterizing the activity of large populations of neurons, combined with rigorous systems engineering (signal processing, machine learning, and real-time systems) to advance the performance of brain-machine interfaces and neuromodulatory devices.

Paul Benkeser is a professor and senior associate chair in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. A member of the Georgia Tech faculty since 1985, he was one of the founding faculty of the Coulter Department in 1998 and served as its first associate chair for undergraduate studies.    

His early research interests were in therapeutic and diagnostic applications of ultrasound. After joining the Coulter Department he redirected his energies toward enhancing undergraduate biomedical engineering  education, with particular interests in integrating problem-driven learning and global experiential learning opportunities in the curriculum. His research and education endeavors have been funded by grants from NIH, NSF, the Department of Veterans Affairs, and the Whitaker Foundation.    

Dr. Benkeser has been active in engineering accreditation activities for ABET since 2002, serving in a number of capacities including program evaluator, EAC Commissioner, and member of its board of delegates. He is a member of the American Institute for Medical and Biological Engineering, Biomedical Engineering Society, and American Society for Engineering Education, and a senior member of the Institute of Electrical and Electronics Engineers.    

He received his BS from Purdue University and MS and PhD from the University of Illinois at Urbana-Champaign, all in electrical engineering.